120 related articles for article (PubMed ID: 21122316)
1. [Expression and gene polymorphisms of B cell activating factor in patients with idiopathic thrombocytopenic purpura].
Liu JQ; Yang LH; Chen JF; Chen XH; Liu XE; Chang LX; Gao Y
Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):586-9. PubMed ID: 21122316
[TBL] [Abstract][Full Text] [Related]
2. [Significance of B cell activating factor of TNF family promoter polymorphisms in patients with immune thrombocytopenic purpura].
Liu JQ; Yang LH; Chen XH; Tan YH; Liu XE; Chen JF; Chang LX; Gao Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):690-3. PubMed ID: 20561430
[TBL] [Abstract][Full Text] [Related]
3. B cell activating factor gene polymorphisms in patients with risk of idiopathic thrombocytopenic purpura.
Abdel-Hamid SM; Al-Lithy HN
Am J Med Sci; 2011 Jul; 342(1):9-14. PubMed ID: 21537154
[TBL] [Abstract][Full Text] [Related]
4. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
[TBL] [Abstract][Full Text] [Related]
5. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.
Emmerich F; Bal G; Barakat A; Milz J; Mühle C; Martinez-Gamboa L; Dörner T; Salama A
Br J Haematol; 2007 Jan; 136(2):309-14. PubMed ID: 17156395
[TBL] [Abstract][Full Text] [Related]
6. [Effect of high-dose dexamethasone on BAFF and Tregs in patients with immune thrombocytopenic purpura.].
Wang CY; Zhu XJ; Hou M; Shi Y; Peng J; Sun JZ; Qin P; Ji XB; Wang L; Wang Q
Zhonghua Xue Ye Xue Za Zhi; 2010 Mar; 31(3):164-7. PubMed ID: 20510105
[TBL] [Abstract][Full Text] [Related]
7. Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.
Zhou Z; Li X; Li J; Su C; Zhuang L; Luo S; Zhang L
J Clin Immunol; 2010 Nov; 30(6):814-22. PubMed ID: 20628793
[TBL] [Abstract][Full Text] [Related]
8. B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood.
Gözmen S; Karapnar TH; Tüfekçi Ö; Vergin C; Yüksel F; İrken G; Ören H
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):494-9. PubMed ID: 24911453
[TBL] [Abstract][Full Text] [Related]
9. Effect of glucocorticoid treatment on BAFF and APRIL expression in patients with immune thrombocytopenia (ITP).
Kamhieh-Milz J; Ghosoun N; Sterzer V; Salama A
Clin Immunol; 2018 Mar; 188():74-80. PubMed ID: 29287794
[TBL] [Abstract][Full Text] [Related]
10. High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia.
Zhu XJ; Shi Y; Sun JZ; Shan NN; Peng J; Guo CS; Qin P; Hou M
J Clin Immunol; 2009 Sep; 29(5):603-10. PubMed ID: 19499314
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between polymorphisms of FCGR2B and susceptibility of children idiopathic thrombocytopenic purpura].
He LY; Huang YJ; Lai DB; Zhao MB; Zhang WY; Xu T; Wang JY; Shi J; Zhao YH; Xu XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):729-33. PubMed ID: 19549396
[TBL] [Abstract][Full Text] [Related]
12. Expression of IL4 (VNTR intron 3) and IL10 (-627) genes polymorphisms in childhood immune thrombocytopenic purpura.
Makhlouf MM; Abd Elhamid SM
Lab Med; 2014; 45(3):211-9. PubMed ID: 25051072
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma +874A/T and interleukin-4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura.
Chen X; Xu J; Chen Z; Zhou Z; Feng X; Zhou Y; Ren Q; Yang R; Han ZC
Eur J Haematol; 2007 Sep; 79(3):191-7. PubMed ID: 17655693
[TBL] [Abstract][Full Text] [Related]
14. [The role of B cell-activating factor secreted by peripheral blood monocyte-derived dendritic cell in chronic idiopathic thrombocytopenic purpura].
Zhou ZH; Zhuang L; Li XY; Li J; Luo SK
Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):599-602. PubMed ID: 21122319
[TBL] [Abstract][Full Text] [Related]
15. Differences in frequency and regulation of T follicular helper cells between newly diagnosed and chronic pediatric immune thrombocytopenia.
Yao X; Li C; Yang J; Wang G; Li C; Xia Y
Blood Cells Mol Dis; 2016 Oct; 61():26-36. PubMed ID: 27667163
[TBL] [Abstract][Full Text] [Related]
16. Expression of B-cell activating factor in pediatric patients with immune thrombocytopenia: a single institutional series and review of literature.
Khalifa KAE; El-Hawy MA; Abo Zeid HM; El-Kholy RM
J Immunoassay Immunochem; 2023 Jan; 44(1):41-55. PubMed ID: 36047579
[TBL] [Abstract][Full Text] [Related]
17. BAFF - an essential survival factor for B cells: Links to genesis of ITP and may be of therapeutic target.
Yu HM; Liu YF; Hou M
Med Hypotheses; 2008; 70(1):40-2. PubMed ID: 17592744
[TBL] [Abstract][Full Text] [Related]
18. Human platelet antigen 1, 2 and 5 gene polymorphisms in Egyptians and their potential association with susceptibility to immune thrombocytopenic purpura in Egyptian patients.
Eyada TK; Amin DG; Samih I; Khedr SM
Hematology; 2018 Mar; 23(2):111-116. PubMed ID: 28823219
[TBL] [Abstract][Full Text] [Related]
19. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia.
Zhu XJ; Shi Y; Peng J; Guo CS; Shan NN; Qin P; Ji XB; Hou M
Blood; 2009 Dec; 114(26):5362-7. PubMed ID: 19794139
[TBL] [Abstract][Full Text] [Related]
20. Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.
Ayad MW; Elbanna AA; Elneily DA; Sakr AS
Mol Diagn Ther; 2015 Apr; 19(2):99-106. PubMed ID: 25800158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
